Navigation Links
Ironwood and Forest to Present Positive Data From Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
Date:9/23/2008

- Comprehensive Phase 3 Clinical Program Initiated -

CAMBRIDGE, Mass. and NEW YORK, Sept. 23 /PRNewswire-FirstCall/ -- Ironwood Pharmaceuticals (formerly Microbia) and Forest Laboratories, Inc. (NYSE: FRX) today announced they will present results of a Phase 2b study investigating linaclotide's safety and efficacy in 419 patients with irritable bowel syndrome with constipation (IBS-C) in a plenary session at the American College of Gastroenterology (ACG) 2008 Annual Scientific Meeting in Orlando, Fla. on October 7, 2008. Analysis of these data indicated that the study met its primary endpoint. Linaclotide is a first-in-class investigational compound being evaluated for its potential to treat IBS-C, chronic constipation (CC), and other gastrointestinal disorders.

(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )

Ironwood and Forest also announced that they have initiated a comprehensive Phase 3 clinical program to evaluate linaclotide's safety and efficacy in patients with either IBS-C or CC. The program will include two pivotal trials in IBS-C patients and two pivotal trials in CC patients, enrolling over 2,500 patients at approximately 250 clinical centers. The companies recently began patient dosing in the first CC trial and expect to initiate the second CC trial by the end of September, 2008. The companies expect to initiate both IBS-C trials by January, 2009.

IBS-C Phase 2b Study

This U.S. and Canada based, twelve-week, randomized, double-blind, placebo-controlled Phase 2b study was designed to assess the safety, efficacy, and dose-response of linaclotide in patients with IBS-C. Patients were ran
'/>"/>

SOURCE Ironwood Pharmaceuticals; Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
2. Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
3. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
4. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
5. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
6. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
7. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
8. Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America
9. ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple Sclerosis
10. New Data Presented at WCTRIMS* Supports the Importance of Early and Sustained Treatment with Betaseron(R)
11. NOVAVAX CEO to Present at 2008 UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Across the global healthcare landscape, the Medical ... development, market education, and regulatory compliance. As emerging markets ... is expected to increase in prominence and follow the ... to research by benchmarking firm, Best Practices, LLC, all ... Medical Affairs. Among companies in India ...
(Date:3/27/2015)... 2015 Levi & Korsinsky announces it has ... OHRP ) concerning possible violations of federal securities laws. ... in connection with its study of the drug OHR-102. ... or contact Joseph E. Levi, Esq. either ... at (212) 363-7500, toll-free: (877) 363-5972. Levi ...
(Date:3/27/2015)... -- Dynatronics Corporation (NASDAQ: DYNT ) today announced that ... Company,s Board of Directors effective March 23, 2015, to fill ... board member Joseph Barton .  "The ... Directors represents an important step forward for the company," said ... "Rich is a proven leader and is well-known for his ...
Breaking Medicine Technology:Medical Affairs Capabilities Expanding in Emerging Marketplaces 2Dynatronics Announces Appointment of Richard J. Linder to Board of Directors 2
... , , CONCORD, Calif. , Feb. 3 ... covering most of the Western United States . Effective February 1, ... been granted an exclusive sales territory encompassing the states of California ... Nevada , Oregon , Washington , Colorado , Utah ...
... , VIENNA, Va. , Feb. ... that Geert Kersten , Chief Executive Officer, will be presenting ... Biotechnology Industry Organization (BIO), the conference will take place February ... Mr. Kersten,s presentation will be on Tuesday, February 9th , ...
Cached Medicine Technology:Pulse Systems Announces New Sales Representation in the Western United States 2Pulse Systems Announces New Sales Representation in the Western United States 3CEL-SCI to Present at 12th Annual BIO CEO & Investor Conference 2
(Date:3/28/2015)... 28, 2015 Take a bite of ... into action. Acids tumble into the stomach, ready to ... valve-like structure lets these acids run amok, triggering a ... common symptom. More than 60 million Americans have heartburn ... where heartburn starts, and how it can be stopped. ...
(Date:3/28/2015)... York (PRWEB) March 28, 2015 ... involving devices manufactured by C.R. Bard, Inc. continue ... in U.S. District Court, Southern District of West ... is serving on the Plaintiffs’ Steering Committee. ... Court has granted certain defendants named in those ...
(Date:3/28/2015)... 2015 Emergency Medical Care (EMC), a ... Manhattan, recently commemorated its three-year anniversary of being the ... addition to 24-hour urgent care, Emergency Medical Care offers ... this time, Emergency Medical Care’s Urgent Care NYC ... pain, eye injuries, ear infections, fevers, insect bites, burns, ...
(Date:3/28/2015)... New York, NY (PRWEB) March 28, 2015 ... 2015 highlighted a problem which could prove critical to ... Why system testing, a critical aspect of data security, ... payment card industry data security report, every major category ... vulnerability scanning and penetration testing. “With all the craziness ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Pitching speed, player’s ... history of shoulder and elbow injuries, according to new research ... ( AOSSM ) Specialty Day. , “Our findings indicate that ... 20% increase in likelihood of a history of injury, a ... a 12% increase likelihood of a history of injury, and ...
Breaking Medicine News(10 mins):Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2
... among the children gets kicked off, with the government ... children will be weighed and provided nutrition diet. // ... Sanjivani Abhiyan (Child Growth Monitoring Drive), were launched by ... Bangadda village in Indore district. ,"The ...
... biological father of his child) has always been a topic ... detailed discussion by anthropologists. // A new study, by Kermyt ... Social Research) that would be published in the June 06 ... On how accurate are men's suspicions of whether or not ...
... being the leading cause of cancer deaths in the world ... that includes more than 37,000 in the UK itself! ... lung cancer, owes its birth to the impairment of a ... in Nashville, have expressed optimism with this finding, which will ...
... particular diet can influence corrective behaviour in prisoners.// ... a product of poor nutrition was tested in a ... become less violent when put on a diet rich ... seafood.,The paper titled “Seafood Consumption and Homicide Mortality”, raised ...
... out to carry out tests to determine the efficacy of ... on Sunday. The program designed to study 40 heart patients ... Sciences, Mahidol University and the Cardiac Institute of Thailand. ... Department, said Thailand did not have any guidelines on this ...
... of genes that are safely ensconced in the systematic pattern of ... genes in the human genome are in an alert state in ... dormant state. ,This trait of genes, called gene silencing ... cover for the genome from viruses, and even cancer, and is ...
Cached Medicine News:Health News:Drive Against Malnutrition Among Children In MP Gets Kicked Off 2Health News:Can Men Gauge Biological Paternity Accurately 2Health News:Novel method conceived, to achieve genome-wide gene silencing. 2
... expanded database containing over 330 species ... VITEK 2 Compact offers enhanced identification ... time (2 to 14 hours), it ... that contaminate production areas and final ...
... is a comprehensive hemodynamic monitoring and ... lab. Patient demographics, clinical hemodynamic ... procedural information all flow seamlessly into ... repetitive data entry. Both ...
... CritiSense first generation product is a ... via four physiological parameters, sensed at the ... state., CritiView illuminates tissue by low power ... emitted from the tissue. The light is ...
PowerMed is a billing software....
Medicine Products: